United States · Bill · HR
H.R. 3155 (108th)
Fair Balance Prescription Drug Advertisement Act of 2003
Introduced
23 September 2003
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
18 August 2025
Summary
Fair Balance Prescription Drug Advertisement Act of 2003 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 23 September 2003
Introduced in House (PDF)
Introduced in House · EN · 23 September 2003
Introduced in House
summary · EN · 23 September 2003
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/house-bill/3155
- Open data entity: https://api.congress.gov/v3/bill/108/hr/3155